Medical Training (Prioritisation) Bill

Debate between Lord Mendelsohn and Lord Winston

Committee stage
Thursday 12th February 2026 Lords Chamber

[Lord Winston (Lab)]

My Lords, it is an honour to support the noble Baroness, Lady Gerada. The best surgical training I had was with a Maltese surgeon, who was absolutely fantastic and taught me lessons I have never forgotten. One has to see that that cross-fertilisation happens across the NHS very often.

[Lord Mendelsohn (Lab)]

My Lords, I support Amendments 15, 16 and 19, in the name of the noble Baroness, Lady Gerada, and supported by the noble Lord, Lord Clement-Jones. It is my first opportunity to speak in the presence of the noble Baroness, Lady Gerada, in this Chamber. She is one of the more extraordinary and fantastic additions to this House in recent years. She has made a massive contribution to our country in medical expertise. The case that she made for these amendments was utterly compelling. I hope the Minister has felt the same inspiration as I did from her words. I also commend the noble Lord, Lord Clement-Jones, who I realise I have now known for 29 years, for another great speech, which again I think added to the strength of these points.

The amendments address an important omission, which has a couple of concerning issues underlying it. The case for why we should continue with this relationship is compelling. We seek to add Malta to the list of jurisdictions whose primary medical qualifications are recognised for prioritisation. As stated, Malta’s medical education system is not merely comparable to that of the United Kingdom; it is formally and historically integrated, through decades of regulatory alignment, shared training structures and sustained institutional partnerships, including the Queen Mary University of London’s Malta campus.

A substantial proportion of the graduates from this campus are United Kingdom nationals and many others hold UK domicile or indefinite leave to remain status. This is a cohort that can be planned for with confidence and absorbed without difficulty within the normal operation of the system, while making a real and practical contribution to the NHS. As the noble Lord, Lord Clement-Jones, said, they provide a valuable workforce capability that does not undermine the consultant pipeline, which is something we have to manage very well. Excluding this cohort of medical students disrupts an established pipeline, separates training from deployment and leaves capacity unused within a system that is under constant pressure. That is not disciplined workforce policy; it is a misalignment between regulation and operational need.

Medical education is one of the United Kingdom’s most significant strategic assets and a central pillar of our global impact in healthcare. It is very important that we maintain alignments and partnerships where they exist. Undermining them does nothing to enhance our reputation as a stable partner for any form of business, let alone the important thing of building relationships in medical research. I hope the Government reflect very carefully on this. A category error has led to a position where, even as recently as 2024, we undertook another solemn commitment—as you do in contracting—which we have now backed away from. That is a terrible place to be in.

The historic connections we have with countries—where we align these things over years and people invest with confidence—must not be undermined, especially when we, essentially, use a free trade agreement as a mechanism to undermine it. This is the wrong way around. This is not strategic planning; it is dodging and weaving between different and vacillating policies. We cannot be subject to this.

I hope the Minister will encourage the Government to reflect very carefully on this. I hope that there will be some positive news about how we can make sure that the countries we have aligned with most closely and have a formal UK affiliation can be brought into this arrangement and that some form of these amendments can be accepted.